Axogen, Inc.
Axogen, Inc. (AXGN) is listed on NASDAQ and classified in Medical Devices, part of the Healthcare sector. It is headquartered in Alachua, United States and has 622 employees. The company is worth $2.15B. Revenue was $225.21M in fiscal 2025, up 20.2% from the year before. It reported a net loss of $15.7M. The share price is 30.7% below its 52-week high of $52.91. 5 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Ken Griffin (Citadel Advisors), at $62.86M. In that quarter, 2 of them opened or added to the position and 2 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▲ +261.8% over 5Y.
today you would have $2,279.13▲ +127.9%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 16 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $32.73 | $16.48 | $6.83 | $9.98 | $9.37 | $17.90 | $17.89 | $20.43 | $28.30 | $9.00 | $5.00 | $3.59 | $4.49 | $2.70 | $2.70 | $3.49 | |
| P/S | 6.3x | 7.5x |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| PHVSPharvaris N.V. | $30.68 | — | 6.4x | 0.00% | -70.46% | $2.15B |
| IMNMImmunome Inc. | $18.26 | — | 3.9x | 0.00% | -64.03% | $2.15B |
| NEONeogenomics Inc | $16.39 | — | 2.7x | 0.00% | -6.33% | $2.11B |
| VCELVericel Corp | $42.97 |
| 3.9x |
| 1.9x |
| 3.1x |
| 3.1x |
| 6.5x |
| 6.7x |
| 9.5x |
| 16.2x |
| 7.2x |
| 5.5x |
| 4.2x |
| 10.2x |
| 39.0x |
| 6.2x |
| 1.4x |
| P/B | 5.9x | 13.2x | 7.0x | 3.1x | 4.2x | 3.5x | 5.9x | 5.4x | 5.4x | 38.8x | 19.9x | 18.3x | — | 819.1x | — | 4.9x | — |
| EPS | -$0.34 | -$0.23 | -$0.51 | -$0.69 | -$0.65 | -$0.60 | -$0.74 | -$0.60 | -$0.31 | -$0.47 | -$0.51 | -$0.99 | -$1.08 | -$0.85 | -$2.77 | -$8.35 |
| Dividend yield | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 28.65% |
| Profit margin | -26.99% | -6.97% | -5.32% | -13.66% | -20.89% | -21.19% | -21.18% | -27.30% | -26.68% | -17.29% | -35.06% | -48.87% | -105.31% | -132.97% | -122.44% | -190.11% | -180.50% |
| ROE | -23.98% | -12.19% | -9.59% | -22.70% | -28.66% | -23.98% | -19.31% | -22.05% | -15.24% | -41.48% | -96.58% | -162.96% | — | -10654.00% | — | -151.84% | — |
Median of the years shown; P/E years above 200x are left out.
| 91.4x |
| 5.9x |
| 0.00% |
| 7.16% |
| $2.2B |
| INSPInspire Medical Systems, Inc. | $72.66 | 16.0x | 2.5x | 0.00% | 17.96% | $2.1B |
| HRMYHarmony Biosciences Holdings, Inc. | $36.03 | 12.3x | 2.1x | 0.00% | 20.46% | $2.1B |